Pascal Van Bleyenbergh

500 total citations
20 papers, 271 citations indexed

About

Pascal Van Bleyenbergh is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Pascal Van Bleyenbergh has authored 20 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Pascal Van Bleyenbergh's work include Antifungal resistance and susceptibility (4 papers), Infectious Diseases and Mycology (3 papers) and Fungal Infections and Studies (3 papers). Pascal Van Bleyenbergh is often cited by papers focused on Antifungal resistance and susceptibility (4 papers), Infectious Diseases and Mycology (3 papers) and Fungal Infections and Studies (3 papers). Pascal Van Bleyenbergh collaborates with scholars based in Belgium, United Kingdom and Netherlands. Pascal Van Bleyenbergh's co-authors include Lieven Dupont, C. Van De Kerkhove, Pieter Goeminne, Daniel Sifrim, Ans Pauwels, Marijke Proesmans, Ann Decraene, Veerle Mertens, Kathleen Blondeau and Ricard Farré and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and CHEST Journal.

In The Last Decade

Pascal Van Bleyenbergh

18 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Van Bleyenbergh Belgium 10 107 97 88 73 32 20 271
Marcin Dziekiewicz Poland 10 79 0.7× 79 0.8× 55 0.6× 94 1.3× 79 2.5× 29 329
Tzong‐Hsi Lee Taiwan 12 87 0.8× 74 0.8× 37 0.4× 197 2.7× 109 3.4× 35 424
Tat-Kin Tsang United States 13 173 1.6× 74 0.8× 30 0.3× 289 4.0× 19 0.6× 28 472
Еlena A. Vishneva Russia 9 99 0.9× 67 0.7× 39 0.4× 24 0.3× 11 0.3× 126 353
P Steiner United States 13 43 0.4× 148 1.5× 152 1.7× 172 2.4× 24 0.8× 23 392
A. De Alessandri Italy 10 216 2.0× 36 0.4× 37 0.4× 162 2.2× 45 1.4× 21 395
S Parry United Kingdom 11 81 0.8× 107 1.1× 66 0.8× 165 2.3× 267 8.3× 20 466
Tapas Sabui India 11 61 0.6× 40 0.4× 52 0.6× 66 0.9× 9 0.3× 41 297
Mitsuo Ohkawa Japan 12 104 1.0× 136 1.4× 46 0.5× 47 0.6× 8 0.3× 45 355
Goohyeon Hong South Korea 10 114 1.1× 123 1.3× 102 1.2× 54 0.7× 5 0.2× 26 301

Countries citing papers authored by Pascal Van Bleyenbergh

Since Specialization
Citations

This map shows the geographic impact of Pascal Van Bleyenbergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Van Bleyenbergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Van Bleyenbergh more than expected).

Fields of papers citing papers by Pascal Van Bleyenbergh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Van Bleyenbergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Van Bleyenbergh. The network helps show where Pascal Van Bleyenbergh may publish in the future.

Co-authorship network of co-authors of Pascal Van Bleyenbergh

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Van Bleyenbergh. A scholar is included among the top collaborators of Pascal Van Bleyenbergh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Van Bleyenbergh. Pascal Van Bleyenbergh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simoens, Steven, et al.. (2025). Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant. Frontiers in Public Health. 12. 1432821–1432821. 1 indexed citations
2.
Lagrou, Katrien, Paul De Munter, Geert M. Verleden, et al.. (2024). COVID-19 Outcomes in Lung Transplant Recipients Following Pre-Exposure Prophylaxis With Tixagevimab-Cilgavimab During the Omicron BA.5 Surge: A Single Center Analysis. Transplant International. 37. 12061–12061. 2 indexed citations
3.
André, Emmanuel, Natalie Lorent, Kurt Beuselinck, et al.. (2024). Multicenter study of the performance of NTM Elite agar for the detection of nontuberculous mycobacteria from patients with cystic fibrosis. Microbiology Spectrum. 12(10). e0273623–e0273623. 1 indexed citations
4.
Dupont, Lieven, Natalie Lorent, Pascal Van Bleyenbergh, et al.. (2023). Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes. SHILAP Revista de lepidopterología. 2023. 1–4.
5.
Daele, Ruth Van, Yves Debaveye, Robin Vos, et al.. (2021). Concomitant use of isavuconazole and CYP3A4/5 inducers: Where pharmacogenetics meets pharmacokinetics. Mycoses. 64(9). 1111–1116. 3 indexed citations
6.
Verleden, Geert M., Laurent Godinas, Natalie Lorent, et al.. (2020). COVID-19 in lung transplant patients: A case series. American Journal of Transplantation. 20(11). 3234–3238. 29 indexed citations
7.
Bos, Saskia, et al.. (2019). An atypical case of a pulmonary mass in an immunocompromised patient. Acta Clinica Belgica. 75(5). 370–374.
8.
Raskin, Jo, Kristina Vermeersch, Stephanie Everaerts, Pascal Van Bleyenbergh, & Wim Janssens. (2018). Do-not-resuscitate orders as part of advance care planning in patients with COPD. ERJ Open Research. 4(1). 116–2017. 9 indexed citations
9.
Hermans, Frederik, Sien Ombelet, Dries Testelmans, et al.. (2016). First‐in‐man observation of Talaromyces marneffei ‐transmission by organ transplantation. Mycoses. 60(3). 213–217. 16 indexed citations
10.
Kerkhove, C. Van De, Pieter Goeminne, Michał Kiciński, et al.. (2016). Continuous alternating inhaled antibiotic therapy in CF: A single center retrospective analysis. Journal of Cystic Fibrosis. 15(6). 802–808. 14 indexed citations
11.
Demeure, Fabian, et al.. (2014). DisseminatedMycobacterium genavenseinfection in a patient with immunosuppressive therapy and lymphoproliferative malignancy. Acta Clinica Belgica. 69(2). 142–145. 7 indexed citations
12.
Munter, Paul De, Pascal Van Bleyenbergh, Walter De Wever, et al.. (2013). Tuberculosis infection following anti-TNF therapy in inflammatory bowel disease, despite negative screening. Journal of Crohn s and Colitis. 8(6). 550–557. 28 indexed citations
13.
Kerkhove, C. Van De, Pieter Goeminne, Pascal Van Bleyenbergh, & Lieven Dupont. (2012). A cohort description and analysis of the effect of gabapentin on idiopathic cough. PubMed. 8(1). 9–9. 27 indexed citations
14.
Pauwels, Ans, Ann Decraene, Kathleen Blondeau, et al.. (2011). Bile Acids in Sputum and Increased Airway Inflammation in Patients With Cystic Fibrosis. CHEST Journal. 141(6). 1568–1574. 67 indexed citations
15.
Simoens, Steven, Jan Verhaegen, Pascal Van Bleyenbergh, Willy Peetermans, & Marc Decramer. (2011). Consumption Patterns and In Vitro Resistance of Streptococcus pneumoniae to Fluoroquinolones. Antimicrobial Agents and Chemotherapy. 55(6). 3051–3053. 15 indexed citations
16.
Maertens, Johan, Wouter Meersseman, & Pascal Van Bleyenbergh. (2009). New therapies for fungal pneumonia. Current Opinion in Infectious Diseases. 22(2). 183–190. 16 indexed citations
17.
Dupont, Lieven, et al.. (2007). Primary Cryptococcal Cellulitis in a Lung Transplant Recipient. The Journal of Heart and Lung Transplantation. 26(3). 285–289. 12 indexed citations
18.
Bleyenbergh, Pascal Van, Benoît Nemery, N. Nolard, & Maurits Demedts. (2001). Recurrent flu-like illness with migrating pulmonary infiltrates of unknown aetiology. Respiratory Medicine. 95(5). 348–356. 3 indexed citations
19.
Thomeer, Michiel, Pascal Van Bleyenbergh, Benoît Nemery, & M. Demedts. (1999). A breathless accountant who blew up balloons. The Lancet. 354(9173). 124–124. 6 indexed citations
20.
Nackaerts, Kristiaan, et al.. (1998). Hemolytic-uremic syndrome caused by gemcitabine. Annals of Oncology. 9(12). 1355–1355. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcin Dziekiewicz Breakdown of academic impact, for papers by Tzong‐Hsi Lee Breakdown of academic impact, for papers by Tat-Kin Tsang Breakdown of academic impact, for papers by Еlena A. Vishneva Breakdown of academic impact, for papers by P Steiner Breakdown of academic impact, for papers by A. De Alessandri Breakdown of academic impact, for papers by S Parry Breakdown of academic impact, for papers by Tapas Sabui Breakdown of academic impact, for papers by Mitsuo Ohkawa Breakdown of academic impact, for papers by Goohyeon Hong
Rankless by CCL
2026